• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Evaluation of cardiovascular risk. What table to use?].

作者信息

Maiques Galán A

机构信息

Especialista en Medicina de Familia y Comunitaria. Centro de Salud de Manises. Valencia. España.

出版信息

Aten Primaria. 2003 Dec;32(10):586-9. doi: 10.1016/s0212-6567(03)79337-8.

DOI:10.1016/s0212-6567(03)79337-8
PMID:14697183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7681860/
Abstract
摘要

相似文献

1
[Evaluation of cardiovascular risk. What table to use?].[心血管风险评估。使用哪种表格？]
Aten Primaria. 2003 Dec;32(10):586-9. doi: 10.1016/s0212-6567(03)79337-8.
2
[Tables of cardiovascular risk and evidence. In defence of the calibrated Framingham table].[心血管风险与证据表。为校准的弗明汉姆表辩护]
Aten Primaria. 2004 Apr 30;33(7):409; author reply 409-11. doi: 10.1016/s0212-6567(04)78898-8.
3
Psoriasis and cardiovascular risk assessment in primary care.基层医疗中银屑病与心血管风险评估
Br J Gen Pract. 2015 Sep;65(638):476. doi: 10.3399/bjgp15X686701.
4
Relocation potentiates obesity and cardiovascular risk: A case-control study on relocatees from the Three Gorges area.搬迁会加剧肥胖和心血管疾病风险：一项针对三峡地区移民的病例对照研究。
J Diabetes. 2016 Sep;8(5):732-5. doi: 10.1111/1753-0407.12419. Epub 2016 Jul 12.
5
Cardiovascular disease in the QUEST-RA study, 10 years later.10年后的QUEST-RA研究中的心血管疾病
Arthritis Res Ther. 2019 Nov 14;21(1):242. doi: 10.1186/s13075-019-2025-5.
6
Discordance of individual risk estimates.个体风险估计的不一致性。
J Am Coll Cardiol. 2010 Aug 24;56(9):743; author reply 743-4. doi: 10.1016/j.jacc.2010.04.034.
7
Big Data Analytics, the Microbiome, Host-omic and Bug-omic Data and Risk for Cardiovascular Disease.大数据分析、微生物组、宿主组学和病原体组学数据与心血管疾病风险
Heart Lung Circ. 2018 Mar;27(3):e26-e27. doi: 10.1016/j.hlc.2017.07.012.
8
Cardiovascular risk assessment--where are we going?心血管风险评估——我们正走向何方？
Prev Cardiol. 2008 Summer;11(3):183-4. doi: 10.1111/j.1751-7141.2008.07770.x.
9
Comparing methods for assessing cardiovascular risk.比较评估心血管风险的方法。
J Hypertens. 2009 Dec;27(12):2342-3. doi: 10.1097/HJH.0b013e3283324684.
10
Cardiovascular risk assessment--time to look beyond cohort studies.心血管风险评估——是时候超越队列研究了。
Int J Epidemiol. 2004 Jun;33(3):614-5. doi: 10.1093/ije/dyh188. Epub 2004 Apr 22.

引用本文的文献

1
[Influence of morbidity, metabolic control, and use of resources in subjects with cardiovascular risk in the primary care setting].[基层医疗环境中心血管疾病风险患者的发病率、代谢控制及资源利用情况的影响]
Aten Primaria. 2008 Sep;40(9):447-54. doi: 10.1157/13126421.
2
[Calculation of coronary risk in primary care: which table is more suitable for our patients?].[基层医疗中冠心病风险的计算：哪种表格更适合我们的患者？]
Aten Primaria. 2007 Mar;39(3):145-9. doi: 10.1157/13099562.
3
[Primary prevention with statins, consensus and risk tables].[他汀类药物的一级预防、共识与风险表]
Aten Primaria. 2005 Jun 15;36(1):31-8. doi: 10.1157/13075929.
4
[Variability in the calculation of coronary risk in type-2 diabetes mellitus].[2型糖尿病患者冠状动脉风险计算的变异性]
Aten Primaria. 2005 Jan;35(1):30-6. doi: 10.1157/13071042.
5
[No-one is a prophet in their own land].[没有人在自己的家乡是先知。]
Aten Primaria. 2004 Jun 30;34(2):107, author reply 107-8. doi: 10.1016/s0212-6567(04)79472-x.
6
[Tables of cardiovascular risk and evidence. In defence of the calibrated Framingham table].[心血管风险与证据表。为校准的弗明汉姆表辩护]
Aten Primaria. 2004 Apr 30;33(7):409; author reply 409-11. doi: 10.1016/s0212-6567(04)78898-8.

本文引用的文献

1
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.欧洲临床实践中心血管疾病预防指南。欧洲及其他学会心血管疾病预防临床实践联合工作组第三次报告
Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.
2
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.欧洲致命性心血管疾病十年风险评估：SCORE项目
Eur Heart J. 2003 Jun;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3.
3
[Coronary risk estimation in Spain using a calibrated Framingham function].[使用校准的弗雷明汉函数对西班牙人群进行冠心病风险评估]
Rev Esp Cardiol. 2003 Mar;56(3):253-61. doi: 10.1016/s0300-8932(03)76861-4.
4
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.弗雷明汉姆冠心病预测评分的验证：多民族调查结果
JAMA. 2001 Jul 11;286(2):180-7. doi: 10.1001/jama.286.2.180.
5
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组第三次报告（成人治疗小组第三次报告）执行摘要
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.
6
Updated New Zealand cardiovascular disease risk-benefit prediction guide.更新后的新西兰心血管疾病风险效益预测指南。
BMJ. 2000 Mar 11;320(7236):709-10. doi: 10.1136/bmj.320.7236.709.
7
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.美国心脏协会/美国心脏病学会科学声明：使用多危险因素评估方程评估心血管风险：美国心脏协会和美国心脏病学会给医疗专业人员的声明
J Am Coll Cardiol. 1999 Oct;34(4):1348-59. doi: 10.1016/s0735-1097(99)00387-3.
8
Primary prevention of coronary heart disease: integrating risk assessment with intervention.冠心病的一级预防：将风险评估与干预相结合。
Circulation. 1999 Aug 31;100(9):988-98. doi: 10.1161/01.cir.100.9.988.
9
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.英国关于临床实践中冠心病预防的联合建议。英国心脏病学会、英国高脂血症协会、英国高血压学会，获英国糖尿病协会认可。
Heart. 1998 Dec;80 Suppl 2(Suppl 2):S1-29.
10
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.1999年世界卫生组织-国际高血压学会高血压管理指南。指南小组委员会。
J Hypertens. 1999 Feb;17(2):151-83.